Compare MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MicroSectors FANG and Innovation 3X Leveraged ETN vs Tenet Healthcare Corporation — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $36.83 (market cap $2.92B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 7.2× MicroSectors FANG and Innovation 3X Leveraged ETN's market cap, and MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MicroSectors FANG and Innovation 3X Leveraged ETN for 19 Days and Tenet Healthcare Corporation for 15 Days on average.
| FNGU | THC | |
|---|---|---|
Market Cap | $2.92B | $20.98B |
Volume | 1,949,737 | 428,008 |
Sector | Leveraged / Inverse | Health |
52-Week High | $37.20 | $280.77 |
52-Week Low | $13.73 | $161.37 |
Typical Hold Time | 19 Days | 15 Days |
Enterprise Value | — | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNGU, a triple-leveraged ETN tracking major tech stocks, trades at $37.2, up 1.92% today with a bullish technical signal from moving averages. Support and resistance levels are tightly clustered near the current price, while oscillators show neutral to overbought conditions. The ETN provides amplified exposure to tech giants but carries inherent leverage risks.
The outlook hinges on the performance of underlying tech holdings; recent news highlights historical volatility, with an 87% loss during past sector downturns. Investors face significant upside potential from tech growth but must weigh extreme volatility and leverage decay risks inherent in the product structure.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MicroSectors FANG and Innovation 3X Leveraged ETN
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
